CYTEK BIOSCIENCES INC (CTKB) Forecast, Price Target & Analyst Ratings

NASDAQ:CTKB • US23285D1090

Current stock price

4.58 USD
-0.02 (-0.43%)
At close:
4.6073 USD
+0.03 (+0.6%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CYTEK BIOSCIENCES INC (CTKB).

Forecast Snapshot

Consensus Price Target

Price Target
$6.29
+ 37.34% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate
44.829M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
78.18%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$6.29
Upside
+ 37.34%
From current price of $4.58 to mean target of $6.29, Based on 11 analyst forecasts
Low
$5.05
Median
$6.12
High
$7.88

Price Target Revisions

1 Month
0.00%
3 Months
7.25%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for CTKB. The average price target is 6.29 USD. This implies a price increase of 37.34% is expected in the next year compared to the current price of 4.58.
The average price target has been revised upward by 7.25% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CTKB Current Analyst RatingCTKB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CTKB Historical Analyst RatingsCTKB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
78.18%
CTKB was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about CTKB.
In the previous month the buy percentage consensus was at a similar level.
CTKB was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-08TD CowenMaintains Buy -> Buy
2025-11-11Piper SandlerMaintains Overweight -> Overweight
2025-05-28Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2025-05-12Goldman SachsMaintains Sell -> Sell
2025-03-19Stephens & Co.Reiterate Overweight -> Overweight
2025-03-04Piper SandlerMaintains Overweight -> Overweight
2024-11-11Piper SandlerMaintains Overweight -> Overweight
2024-08-13Piper SandlerMaintains Overweight -> Overweight
2024-05-13Piper SandlerMaintains Overweight -> Overweight
2024-03-06Piper SandlerMaintains Overweight -> Overweight
2024-02-29Goldman SachsMaintains Buy -> Buy
2023-12-14Stephens & Co.Initiate Overweight
2023-11-09Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-10-24Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-10-16Piper SandlerMaintains Overweight -> Overweight
2023-07-19Raymond JamesInitiate Market Perform
2023-05-11Morgan StanleyMaintains Equal-Weight -> Equal-Weight
2023-05-10Goldman SachsMaintains Buy
2023-03-07Piper SandlerMaintains Overweight
2023-03-02Goldman SachsMaintains Buy
2023-03-02Morgan StanleyMaintains Equal-Weight
2022-08-18Piper SandlerMaintains Overweight
2022-08-12Morgan StanleyMaintains Equal-Weight
2022-08-11Goldman SachsMaintains Buy
2022-07-14Goldman SachsMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 6, 2026
Period
Q1 / 2026
EPS Estimate
-$0.08
Revenue Estimate
44.829M
Revenue Q2Q
8.13%
EPS Q2Q
15.00%
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
-1.01%
Revenue (3 Months)
-0.45%
EPS (1 Month)
19.64%
EPS (3 Months)
14.29%

Next Earnings Summary

CTKB is expected to report earnings on 5/6/2026. The consensus EPS estimate for the next earnings is -0.08 USD and the consensus revenue estimate is 44.83M USD.
The next earnings revenue estimate has been revised downward by 0.45% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
CTKB revenue by date.CTKB revenue by date.
193.015M
17.69%		200.453M
3.85%		201.493M
0.52%		212.42M
5.42%		227.35M
7.03%		248.35M
9.24%		264.08M
6.33%		287.74M
8.96%
EBITDA
YoY % growth
CTKB ebitda by date.CTKB ebitda by date.
-21.797M
-3,258.99%		-13.311M
38.93%		-32.805M
-146.45%		3.086M
109.41%		14.159M
358.81%		17.007M
20.11%		N/AN/A
EBIT
YoY % growth
CTKB ebit by date.CTKB ebit by date.
-27.845M
-1,446.94%		-20.523M
26.30%		-40.384M
-96.77%		-38.521M
4.61%		-32.895M
14.61%		-26.393M
19.77%		-21.42M
18.84%		-13.566M
36.67%
Operating Margin
CTKB operating margin by date.CTKB operating margin by date.
-14.43%-10.24%-20.04%-18.13%-14.47%-10.63%-8.11%-4.71%
EPS
YoY % growth
CTKB eps by date.CTKB eps by date.
0.05
-65.00%		-0.05
-202.04%		-0.21
-320.00%		-0.25
-18.19%		-0.20
17.81%		-0.15
25.00%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.08
15.00%		-0.06
-44.51%		-0.05
-27.50%		-0.02
42.63%		-0.09
-13.33%		-0.06
-5.88%		-0.04
30.00%		0.01
122.22%		-0.10
-17.65%		-0.05
16.67%		-0.03
14.29%
Revenue
Q2Q % growth		44.829M
8.13%		50.453M
10.64%		55.481M
6.10%		60.374M
-2.84%		49.311M
10.00%		54.924M
8.86%		60.721M
9.44%		66.788M
10.62%		56.61M
14.80%		61.506M
11.98%		67.422M
11.04%
EBITDA
Q2Q % growth		-4.739M
63.83%		612K
108.92%		2.522M
171.87%		5.873M
195.87%		-1.563M
67.02%		715.02K
16.83%		4.511M
78.87%		10.164M
73.06%		N/AN/AN/A
EBIT
Q2Q % growth		-14.743M
1.55%		-11.02M
-3.72%		-7.821M
14.92%		-4.083M
27.01%		-13.176M
10.63%		-9.273M
15.85%		-6.457M
17.43%		-876.69K
78.53%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CTKB Yearly Revenue VS EstimatesCTKB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
CTKB Yearly EPS VS EstimatesCTKB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 -0.2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
8.33%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
7.35%
Revenue Next 5 Year
7.46%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
34.41%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CYTEK BIOSCIENCES INC / CTKB Forecast FAQ

What is the average price target for CYTEK BIOSCIENCES INC (CTKB) stock?

11 analysts have analysed CTKB and the average price target is 6.29 USD. This implies a price increase of 37.34% is expected in the next year compared to the current price of 4.58.

What is the next earnings date for CTKB stock?

CYTEK BIOSCIENCES INC (CTKB) will report earnings on 2026-05-06, after the market close.

What are the consensus estimates for CYTEK BIOSCIENCES INC (CTKB) next earnings?

The consensus EPS estimate for the next earnings of CYTEK BIOSCIENCES INC (CTKB) is -0.08 USD and the consensus revenue estimate is 44.83M USD.

Can you provide the consensus rating for CYTEK BIOSCIENCES INC stock?

The consensus rating for CYTEK BIOSCIENCES INC (CTKB) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.